To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ZNF281TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
298 supporting clones for gene ZNF281 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DA398920 thalamus .a-u 1 to 568 2 to 569   tiling clone, capped   568/568
(100 %)
0 diff
(100 %id)
DA097669 cerebellum .a-u 4 to 473 2 to 471   capped   470/470
(100 %)
0 diff
(100 %id)
DB148239 thymus .a-u 6 to 189 2 to 185   capped   184/184
(100 %)
0 diff
(100 %id)
BP222322   .a-u 50 to 627 1 to 579       579/582
(99 %)
3 diff
(99.5 %id)
AF125158   .a-u 310 to 3337 3 to 3029   tiling clone,   3027/3029
(99 %)
6 diff
(99.9 %id)
BC051905 Skin, melanotic melanoma. .a-u 315 to 3346 1 to 3032 H206Y tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 3032/3032
(100 %)
3 diff
(100.0 %id)
DB345907 thymus .a-u 2774 to 3318 546 to 1       546/546
(100 %)
1 diff
(99.9 %id)
DA113419 cerebellum .b 1 to 604 2 to 605   capped   604/604
(100 %)
1 diff
(99.9 %id)
DA726642   .b 1 to 332 2 to 335   capped   334/334
(100 %)
2 diff
(99.5 %id)
DA752824   .b 1 to 502 2 to 503   capped   502/502
(100 %)
0 diff
(100 %id)
DA760281   .b 1 to 541 2 to 542   tiling clone, capped   541/541
(100 %)
0 diff
(100 %id)
DA770402 brain .b 1 to 558 2 to 560   capped   559/559
(100 %)
1 diff
(99.9 %id)
DA770675 brain .b 1 to 583 2 to 585   capped   584/584
(100 %)
2 diff
(99.7 %id)
DB078257 testis .b 1 to 491 2 to 492   capped   491/491
(100 %)
1 diff
(99.8 %id)
AK027284 whole embryo, mainly head .b 2 to 1739 1 to 1738   available from FLJ,   1738/1738
(100 %)
1 diff
(100.0 %id)
DA568915 whole embryo, mainly head .b 3 to 695 2 to 693   capped   692/692
(100 %)
1 diff
(99.9 %id)
DB152491 thymus .b 5 to 606 2 to 603   capped   602/602
(100 %)
0 diff
(100 %id)
AL524396 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 14 to 877 1 to 861       861/861
(100 %)
12 diff
(98.7 %id)
DA604188   .b 18 to 526 2 to 510   capped   509/509
(100 %)
0 diff
(100 %id)
BC060820 Placenta, normal .b 20 to 3533 1 to 3514 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 3514/3514
(100 %)
1 diff
(100.0 %id)
NM_012482.3   .b 20 to 3533 1 to 3514 exact RefSeq, AAA Possibly primed on the genome, locally A rich (17/20 A in genome downstream of last aligned base) 3514/3514
(100 %)
1 diff
(100.0 %id)
BP284362 bone marrow .b 22 to 603 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
DA241337 brain .b 23 to 594 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
DA505773 brain .b 23 to 422 2 to 401   capped   400/400
(100 %)
0 diff
(100 %id)
DA740233   .b 23 to 585 2 to 568   capped   567/567
(100 %)
5 diff
(99.2 %id)
DA796753 brain .b 23 to 573 2 to 553   capped   552/552
(100 %)
1 diff
(99.9 %id)
DA854060 placenta .b 24 to 604 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA661599   .b 26 to 597 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
BP283309 bone marrow .b 27 to 608 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA577428   .b 28 to 589 2 to 563   capped   562/563
(99 %)
2 diff
(99.7 %id)
DA725573   .b 28 to 597 2 to 572   capped   571/572
(99 %)
2 diff
(99.7 %id)
BP198988 brain .b 31 to 612 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA769079 brain .b 33 to 440 2 to 409   capped   408/408
(100 %)
0 diff
(100 %id)
DB135328 thymus .b 33 to 589 2 to 555   capped   554/554
(100 %)
1 diff
(99.9 %id)
BQ423132 melanotic melanoma, skin .b 36 to 633 1 to 599       599/909
(65 %)
12 diff
(98.7 %id)
DA769212 brain .b 40 to 467 2 to 434   capped   433/433
(100 %)
5 diff
(98.9 %id)
DA754210   .b 41 to 430 2 to 392   capped   391/391
(100 %)
1 diff
(99.8 %id)
DB074620 testis .b 41 to 246 2 to 215   capped   214/214
(100 %)
10 diff
(95.4 %id)
DA697482   .b 43 to 606 2 to 566   capped   565/567
(99 %)
2 diff
(99.7 %id)
CN357226 embryonic stem cells, cell lines H1, H7, andH9 .b 48 to 372 1 to 325       325/325
(100 %)
0 diff
(100 %id)
CN265976 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 52 to 311 1 to 269       269/269
(100 %)
9 diff
(96.7 %id)
CN357228 embryonic stem cells, cell lines H1, H7, andH9 .b 52 to 503 8 to 459       452/459
(98 %)
6 diff
(98.7 %id)
AK022916   .b 69 to 3114 1 to 3046 F63L F482L L635I tiling clone, available from FLJ,   3046/3046
(100 %)
3 diff
(100.0 %id)
AU128449   .b 70 to 533 2 to 464   capped   463/463
(100 %)
3 diff
(99.4 %id)
DA494682 brain .b 73 to 649 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DA577951   .b 73 to 635 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA655445   .b 73 to 623 2 to 564   capped   563/563
(100 %)
19 diff
(96.7 %id)
BU167092 melanotic melanoma, skin .b 112 to 642 1 to 538       538/1021
(52 %)
17 diff
(98.4 %id)
AA176120   .b 113 to 442 1 to 332       332/332
(100 %)
7 diff
(97.9 %id)
TI_1948210023   .b 124 to 981 131 to 984       854/1307
(65 %)
6 diff
(99.6 %id)
TI_1948210229   .b 124 to 979 127 to 988       862/1332
(64 %)
6 diff
(99.6 %id)
TI_1948210446   .b 124 to 914 121 to 924       804/1385
(58 %)
21 diff
(98.5 %id)
EL734080 mixed .b 127 to 706 1 to 580       580/580
(100 %)
11 diff
(98.2 %id)
DA569338 whole embryo, mainly head .b 128 to 810 2 to 684   capped   683/685
(99 %)
3 diff
(99.6 %id)
DA743101   .b 128 to 615 2 to 489   capped   488/488
(100 %)
0 diff
(100 %id)
DA033089   .b 283 to 847 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
DA380251 thalamus .b 353 to 898 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
DA933498 Spleen .b 425 to 979 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
AV698540 hepatocellular carcinoma .b 456 to 774 1 to 319       319/338
(94 %)
1 diff
(99.8 %id)
AA297293 Embryo, 8 weeks .b 517 to 769 1 to 253       253/253
(100 %)
0 diff
(100 %id)
BP290222 lung .b 557 to 1138 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BF763932 colon_est .b 560 to 919 1 to 360       360/372
(96 %)
4 diff
(99.0 %id)
BF764778 colon_est .b 626 to 996 1 to 375       375/375
(100 %)
21 diff
(94.4 %id)
AJ132591 Liver .b 629 to 3102 47 to 2521   AAA   2475/2521
(98 %)
10 diff
(99.7 %id)
BQ304602 breast .b 684 to 1087 430 to 22       409/430
(95 %)
0 diff
(100 %id)
ES312807 beard hair, skin .b 686 to 845 1 to 160       160/160
(100 %)
0 diff
(100 %id)
AA158166 Pancreas .b 817 to 1300 1 to 488       488/488
(100 %)
4 diff
(99.2 %id)
DA689839   .b 986 to 1534 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA572408 whole embryo, mainly body .b 1051 to 1859 2 to 808   capped   807/807
(100 %)
8 diff
(99.1 %id)
FN175866 breast carcinoma .b 1154 to 1249 1 to 92       92/92
(100 %)
4 diff
(95.7 %id)
DB355966 whole embryo, mainly head .b 1176 to 1739 565 to 1       565/565
(100 %)
13 diff
(97.7 %id)
DB355491 whole embryo, mainly head .b 1190 to 1739 548 to 1       548/553
(99 %)
11 diff
(98.1 %id)
BQ379928 uterus_tumor .b 1311 to 1738 431 to 4       428/431
(99 %)
0 diff
(100 %id)
DA363654 subthalamic nucleus .b 1354 to 1926 2 to 576   capped   575/575
(100 %)
2 diff
(99.7 %id)
BP380411 uterus .b 1413 to 1989 1 to 579       579/579
(100 %)
8 diff
(98.7 %id)
EC513311 Prostate .b 1441 to 1545 1 to 105       105/105
(100 %)
0 diff
(100 %id)
BG611645 adenocarcinoma, Prostate .b 1489 to 2222 1 to 748       748/752
(99 %)
29 diff
(96.2 %id)
BP231327 muscle .b 1552 to 2131 1 to 580       580/582
(99 %)
3 diff
(99.5 %id)
FN134709 breast carcinoma .b 1580 to 1688 1 to 112       112/112
(100 %)
7 diff
(93.8 %id)
DW415971 Liver .b 1644 to 1936 17 to 311       295/311
(94 %)
6 diff
(98.1 %id)
BP293395 lung .b 1649 to 2231 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
BP293613 lung .b 1649 to 2231 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
AW068780 Bone, Hip .b 1697 to 2153 9 to 469       461/469
(98 %)
6 diff
(98.8 %id)
AU122253 mammary gland .b 1715 to 2546 2 to 831   capped   830/830
(100 %)
4 diff
(99.6 %id)
TI_1948210231   .b 1727 to 2813 1219 to 130       1090/1320
(82 %)
0 diff
(100 %id)
FN117907 breast carcinoma .b 1790 to 1886 97 to 1     Submitted on the opposite strand 97/97
(100 %)
0 diff
(100 %id)
CB142445 Liver .b 1812 to 2381 1 to 570       570/570
(100 %)
4 diff
(99.3 %id)
TI_1948210448   .b 1828 to 2813 1114 to 127       988/1302
(75 %)
0 diff
(100 %id)
BX349917 Neuroblastoma Cot 25-normalized .b 1842 to 2770 926 to 1       926/926
(100 %)
12 diff
(98.8 %id)
BQ225860 embryonal carcinoma, cell line, testis .b 1846 to 2453 1 to 611       611/992
(61 %)
13 diff
(98.7 %id)
TI_1948210447   .b 1892 to 2813 1044 to 126       919/1386
(66 %)
0 diff
(100 %id)
TI_1948210025   .b 1911 to 2813 1059 to 138       922/1335
(69 %)
0 diff
(100 %id)
TI_1948210675   .b 1926 to 2813 1009 to 124       886/1349
(65 %)
0 diff
(100 %id)
TI_1948210230   .b 1929 to 2813 1004 to 127       878/1350
(65 %)
0 diff
(100 %id)
BM450720 eye, retinoblastoma .b 1930 to 2698 1 to 773       773/1071
(72 %)
17 diff
(98.5 %id)
BP208910 cerebellum .b 1998 to 2582 1 to 584       584/584
(100 %)
1 diff
(99.9 %id)
TI_1948210024   .b 2016 to 2813 914 to 122       793/1393
(56 %)
0 diff
(100 %id)
BX282281 eye, retinoblastoma .b 2024 to 2414 1 to 391       391/391
(100 %)
0 diff
(100 %id)
TI_1948210676   .b 2028 to 2813 935 to 144       792/1388
(57 %)
0 diff
(100 %id)
FN174365 breast carcinoma .b 2135 to 2253 1 to 118       118/120
(98 %)
2 diff
(98.4 %id)
TI_149305670   .b 2135 to 3143 1055 to 63       993/1095
(90 %)
0 diff
(100 %id)
TI_149307732   .b 2154 to 2459 478 to 783     Submitted on the opposite strand 306/1066
(28 %)
4 diff
(99.7 %id)
CN357225 embryonic stem cells, cell lines H1, H7, andH9 .b 2201 to 2789 1 to 586       586/586
(100 %)
5 diff
(99.2 %id)
FN052059 breast carcinoma .b 2220 to 2326 107 to 1     Submitted on the opposite strand 107/108
(99 %)
0 diff
(100 %id)
BM699340 eye, fetal eyes .b 2279 to 2614 1 to 336   fully sequenced,   336/336
(100 %)
0 diff
(100 %id)
BU685987 lung, Primary Lung Epithelial Cells .b 2414 to 3114 717 to 17   AAA   701/701
(100 %)
1 diff
(99.9 %id)
BQ010225 Chondrosarcoma, Left Pubic Bone .b 2453 to 3114 678 to 17   AAA   662/662
(100 %)
0 diff
(100 %id)
BM558244 duodenal adenocarcinoma, cell line, small intestine .b 2528 to 3530 1 to 1015       1015/1019
(99 %)
20 diff
(98.1 %id)
AU150732   .b 2533 to 3114 578 to 1       578/578
(100 %)
14 diff
(97.6 %id)
AA176121   .b 2534 to 3114 583 to 1       583/593
(98 %)
9 diff
(98.5 %id)
FN107711 breast carcinoma .b 2542 to 2627 1 to 86       86/92
(93 %)
1 diff
(99.0 %id)
DB359420 whole embryo, mainly body .b 2550 to 3102 553 to 1       553/560
(98 %)
17 diff
(97.0 %id)
AF086540   .b 2575 to 3114 1 to 540   AAA   540/540
(100 %)
0 diff
(100 %id)
W96110 heart .b 2575 to 3053 1 to 481       481/481
(100 %)
2 diff
(99.6 %id)
BM670001 eye, fetal eyes .b 2584 to 3063 488 to 9   fully sequenced,   480/488
(98 %)
6 diff
(98.8 %id)
DA022524   .b 2593 to 3166 2 to 576   capped   575/575
(100 %)
1 diff
(99.9 %id)
AW068518 Bone, Hip .b 2595 to 3061 474 to 8       467/474
(98 %)
0 diff
(100 %id)
AI803645   .b 2598 to 3105 508 to 1       508/508
(100 %)
0 diff
(100 %id)
AW021593 cochlea, ear .b 2620 to 3124 7 to 511       505/526
(96 %)
3 diff
(99.5 %id)
BE349011 malignant melanoma, metastatic to lymphnode, skin .b 2623 to 3125 503 to 1       503/503
(100 %)
0 diff
(100 %id)
DA057246 cerebellum .b 2646 to 3235 2 to 591   capped   590/590
(100 %)
0 diff
(100 %id)
AI819472 lymph node, lymphoma, follicular mixed small and largecell .b 2651 to 3125 476 to 1       476/476
(100 %)
1 diff
(99.8 %id)
W96111 heart .b 2656 to 3115 467 to 1       467/467
(100 %)
10 diff
(97.9 %id)
AI086548 senescent fibroblast .b 2659 to 3108 450 to 1       450/450
(100 %)
0 diff
(100 %id)
DB558756 hypothalamus .b 2678 to 3100 1 to 423     Submitted on the opposite strand 423/425
(99 %)
1 diff
(99.8 %id)
AI493984 Kidney .b 2684 to 3115 432 to 1       432/432
(100 %)
0 diff
(100 %id)
AA631465 thyroid .b 2689 to 3067 8 to 386       379/386
(98 %)
6 diff
(98.5 %id)
CD358910 testis .b 2690 to 3323 1 to 639       639/923
(69 %)
11 diff
(98.9 %id)
AW291550   .b 2693 to 3142 467 to 16   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 452/452
(100 %)
5 diff
(98.9 %id)
AA832242 germinal center B cell .b 2696 to 3123 428 to 1       428/428
(100 %)
1 diff
(99.8 %id)
AI369724 anaplastic oligodendroglioma, brain .b 2698 to 3103 406 to 1       406/406
(100 %)
0 diff
(100 %id)
FN051025 breast carcinoma .b 2699 to 2781 1 to 83       83/84
(98 %)
1 diff
(98.9 %id)
AI580288 Kidney .b 2702 to 3114 411 to 1       411/411
(100 %)
2 diff
(99.6 %id)
CB112678 Liver .b 2702 to 3225 1 to 523       523/523
(100 %)
1 diff
(99.9 %id)
AI095278 senescent fibroblast .b 2712 to 3107 396 to 1       396/396
(100 %)
0 diff
(100 %id)
BM979458 lung, Primary Lung Epithelial Cells .b 2717 to 3102 413 to 29   AAA   385/610
(63 %)
9 diff
(98.6 %id)
AI914376 pooled .b 2722 to 3126 408 to 1       408/408
(100 %)
3 diff
(99.3 %id)
CB148111 Liver .b 2752 to 3102 10 to 360       351/405
(86 %)
1 diff
(99.8 %id)
BE705963 head_neck .b 2767 to 2921 1 to 158       158/158
(100 %)
6 diff
(96.3 %id)
BQ338206 nervous_normal .b 2775 to 3000 226 to 4       223/226
(98 %)
0 diff
(100 %id)
AA512896 normal prostate, Prostate .b 2794 to 3129 336 to 1       336/336
(100 %)
0 diff
(100 %id)
AI221386 pooled .b 2799 to 3102 317 to 14   AAA   304/304
(100 %)
0 diff
(100 %id)
DA273071 caudate nucleus .b 2805 to 3369 2 to 566   capped   565/565
(100 %)
3 diff
(99.5 %id)
AI926078 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .b 2819 to 3125 309 to 1       309/309
(100 %)
5 diff
(98.4 %id)
FN053515 breast carcinoma .b 2839 to 2947 109 to 1     Submitted on the opposite strand 109/109
(100 %)
1 diff
(99.1 %id)
CX758852 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 2854 to 3031 207 to 30   AAA   178/182
(97 %)
4 diff
(97.9 %id)
AU147876 mammary gland .b 2970 to 3533 563 to 1       563/563
(100 %)
15 diff
(97.4 %id)
FN121758 breast carcinoma .b 2994 to 3098 1 to 105       105/107
(98 %)
1 diff
(99.1 %id)
GD140275   .b 3066 to 3137 7 to 78       72/81
(88 %)
2 diff
(97.6 %id)
BF852482 lung_normal .b 3085 to 3297 216 to 7     Submitted on the opposite strand 210/220
(95 %)
0 diff
(100 %id)
DB073291 testis .c 1 to 522 10 to 531   tiling clone, capped   522/530
(98 %)
6 diff
(98.9 %id)
BP216938 corpus callosum .c 331 to 918 1 to 588       588/588
(100 %)
0 diff
(100 %id)
DB465947 hippocampus .c 331 to 747 1 to 415       415/415
(100 %)
12 diff
(97.2 %id)
DB475610 hippocampus .c 331 to 791 1 to 461       461/461
(100 %)
0 diff
(100 %id)
DA715672   .c 332 to 896 2 to 573   capped   571/572
(99 %)
17 diff
(97.1 %id)
DA758004   .c 332 to 827 2 to 497   capped   496/496
(100 %)
0 diff
(100 %id)
DA794255 brain .c 332 to 850 2 to 520   capped   519/519
(100 %)
0 diff
(100 %id)
DA858456 placenta .c 332 to 904 2 to 574   capped   573/574
(99 %)
1 diff
(99.9 %id)
DB087841 testis .c 332 to 834 2 to 505   capped   504/504
(100 %)
1 diff
(99.9 %id)
DB136051 thymus .c 332 to 827 2 to 497   capped   496/496
(100 %)
1 diff
(99.8 %id)
DB150929 thymus .c 332 to 599 2 to 269   capped   268/268
(100 %)
0 diff
(100 %id)
DB082755 testis .c 333 to 895 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA054166 cerebellum .c 349 to 826 2 to 479   capped   478/478
(100 %)
0 diff
(100 %id)
DA883643   .c 350 to 893 2 to 548   capped   547/547
(100 %)
4 diff
(99.3 %id)
DA030667   .c 352 to 921 2 to 570   capped   569/569
(100 %)
3 diff
(99.5 %id)
DA121775 cerebellum .c 354 to 682 2 to 332   capped   331/331
(100 %)
3 diff
(99.1 %id)
DA128830 cerebellum .c 354 to 941 2 to 592   capped   591/591
(100 %)
3 diff
(99.5 %id)
DB148832 thymus .c 354 to 569 2 to 218   capped   217/217
(100 %)
1 diff
(99.6 %id)
DB185863 liver, tumor tissue .c 354 to 942 2 to 589   capped   588/588
(100 %)
2 diff
(99.7 %id)
DA522170 brain .c 355 to 921 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
DB152018 thymus .c 359 to 949 2 to 594   capped   593/593
(100 %)
3 diff
(99.5 %id)
DA049203   .c 364 to 950 2 to 590   capped   589/589
(100 %)
2 diff
(99.7 %id)
DA792460 brain .c 364 to 765 2 to 403   capped   402/402
(100 %)
1 diff
(99.8 %id)
DB069443 testis .c 364 to 524 2 to 162   capped   161/161
(100 %)
0 diff
(100 %id)
BP230665 brain .c 371 to 950 1 to 583       583/583
(100 %)
8 diff
(98.7 %id)
DA549925   .c 372 to 948 2 to 583   capped   582/582
(100 %)
7 diff
(98.8 %id)
DA791358 brain .c 372 to 926 2 to 557   capped   556/556
(100 %)
1 diff
(99.9 %id)
DB097677 testis .c 372 to 941 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DN995988 breast cancer, Mammary gland (cancer tissue) .c 375 to 1033 8 to 669       662/669
(98 %)
9 diff
(98.7 %id)
AJ132592 Liver .c 381 to 3437 27 to 3084 exact tiling clone, AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 3058/3084
(99 %)
7 diff
(99.8 %id)
BP215712 corpus callosum .c 395 to 972 1 to 581       581/583
(99 %)
24 diff
(95.9 %id)
BP348586 brain .c 397 to 979 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA020176   .c 398 to 965 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA629448 Kidney .c 398 to 941 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA770712 brain .c 398 to 979 2 to 584   capped   583/583
(100 %)
2 diff
(99.7 %id)
DA817188   .c 398 to 789 2 to 393   capped   392/392
(100 %)
0 diff
(100 %id)
DA024709   .c 404 to 932 2 to 530   capped   529/529
(100 %)
1 diff
(99.9 %id)
DA308420 hippocampus .c 404 to 965 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
DA771605 brain .c 404 to 974 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
DA779123 brain .c 404 to 950 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA790844 brain .c 404 to 868 2 to 467   capped   466/466
(100 %)
3 diff
(99.4 %id)
DA994156 synovial membrane tissue from rheumatioidarthritis .c 404 to 761 2 to 366   capped   365/365
(100 %)
8 diff
(97.9 %id)
DA744495   .c 418 to 654 235 to 471   capped   237/470
(50 %)
6 diff
(98.8 %id)
AA085487   .c 1502 to 1884 1 to 388       388/388
(100 %)
5 diff
(98.8 %id)
AK022921   .c 1705 to 4290 1 to 2586   tiling clone, available from FLJ,   2586/2586
(100 %)
3 diff
(99.9 %id)
AU128470   .c 1705 to 2353 2 to 651   capped   650/652
(99 %)
11 diff
(98.4 %id)
AK021707 whole embryo, mainly head .c 2032 to 3877 1 to 1846   available from FLJ,   1846/1846
(100 %)
1 diff
(100.0 %id)
AU118807 whole embryo, mainly head .c 2033 to 2927 2 to 891   capped   890/893
(99 %)
18 diff
(98.0 %id)
BI496067 cochlea, ear .c 2939 to 3314 1 to 377   fully sequenced,   377/377
(100 %)
5 diff
(98.7 %id)
AL562343 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .c 2952 to 3808 867 to 10       858/867
(98 %)
0 diff
(100 %id)
BM473756 duodenal adenocarcinoma, cell line, small intestine .c 3205 to 4252 13 to 1072   AAA Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) 1060/1072
(98 %)
6 diff
(99.5 %id)
DA602718   .c 3247 to 3798 2 to 555   capped   554/554
(100 %)
2 diff
(99.7 %id)
BI496066 cochlea, ear .c 3284 to 3888 603 to 1   fully sequenced,   603/603
(100 %)
3 diff
(99.6 %id)
AU145285 whole embryo, mainly head .c 3315 to 3877 558 to 1       558/583
(95 %)
18 diff
(97.0 %id)
BQ189329 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 3326 to 3987 1 to 662       662/662
(100 %)
1 diff
(99.9 %id)
TI_151731608   .c 3327 to 4079 809 to 57       753/1039
(72 %)
0 diff
(100 %id)
R32251 placenta .c 3331 to 3451 1 to 121       121/121
(100 %)
0 diff
(100 %id)
DB544432 hippocampus .c 3374 to 3873 1 to 512     Submitted on the opposite strand 512/512
(100 %)
14 diff
(97.3 %id)
AA908978 pooled .c 3383 to 3868 486 to 1       486/486
(100 %)
0 diff
(100 %id)
AA687264 germinal center B cell .c 3387 to 3875 492 to 3       490/492
(99 %)
0 diff
(100 %id)
BF952666 nervous_normal .c 3405 to 3764 371 to 11       361/418
(86 %)
0 diff
(100 %id)
AW905381 nervous_normal .c 3409 to 3767 369 to 9       361/373
(96 %)
0 diff
(100 %id)
DB532888 hippocampus .c 3452 to 3873 1 to 422     Submitted on the opposite strand 422/422
(100 %)
1 diff
(99.8 %id)
N47468 multiple sclerosis lesions .c 3480 to 3941 1 to 468       468/471
(99 %)
13 diff
(97.3 %id)
AW953662   .c 3487 to 4163 1 to 677       677/684
(98 %)
20 diff
(97.1 %id)
AA995034 pooled .c 3491 to 3856 366 to 1       366/366
(100 %)
2 diff
(99.5 %id)
CN295257 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 3499 to 4125 1 to 627       627/627
(100 %)
1 diff
(99.9 %id)
AW370214 breast .c 3516 to 3845 330 to 1       330/330
(100 %)
16 diff
(95.2 %id)
BF952307 nervous_normal .c 3526 to 3742 223 to 6       218/223
(97 %)
0 diff
(100 %id)
C15488   .c 3550 to 3915 1 to 364       364/364
(100 %)
5 diff
(98.7 %id)
D60171   .c 3550 to 3759 1 to 209       209/209
(100 %)
1 diff
(99.6 %id)
D80625 brain .c 3550 to 3842 1 to 293       293/293
(100 %)
1 diff
(99.7 %id)
D60762   .c 3550 to 3877 1 to 328   fully sequenced,   328/328
(100 %)
8 diff
(97.6 %id)
D61250   .c 3550 to 3874 1 to 325       325/333
(97 %)
1 diff
(99.7 %id)
D81729 brain .c 3550 to 3933 1 to 382       382/382
(100 %)
5 diff
(98.7 %id)
AA360267   .c 3556 to 3762 1 to 208       208/208
(100 %)
3 diff
(98.6 %id)
BU941244 mixed (pool of 40 RNAs) .c 3624 to 4292 1 to 669       669/673
(99 %)
4 diff
(99.5 %id)
BG493128 lung, mucoepidermoid carcinoma .c 3656 to 4308 1 to 647       647/724
(89 %)
13 diff
(98.3 %id)
AA354749   .c 3692 to 4055 1 to 364       364/364
(100 %)
3 diff
(99.2 %id)
AU150752   .c 3722 to 4290 566 to 1       566/574
(98 %)
8 diff
(98.7 %id)
BF671845 muscle (skeletal) .c 3727 to 4305 1 to 585       585/621
(94 %)
15 diff
(97.6 %id)
AI796083 Kidney .c 3733 to 4281 558 to 10       549/558
(98 %)
0 diff
(100 %id)
AI628629 Kidney .c 3736 to 4290 555 to 1       555/555
(100 %)
0 diff
(100 %id)
BE551046 carcinoid, lung .c 3770 to 4291 522 to 1       522/522
(100 %)
1 diff
(99.9 %id)
BE218621 carcinoid, lung .c 3799 to 4289 491 to 1       491/491
(100 %)
0 diff
(100 %id)
D60170   .c 3829 to 4290 459 to 1       459/460
(99 %)
3 diff
(99.4 %id)
AI334384 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 3833 to 4289 457 to 1       457/457
(100 %)
0 diff
(100 %id)
CN295258 embryonic stem cells, cell lines H1, H7, andH9 .c 3844 to 4297 1 to 454       454/454
(100 %)
0 diff
(100 %id)
D60761   .c 3850 to 4290 438 to 1   fully sequenced,   438/438
(100 %)
5 diff
(98.9 %id)
AI380826 B-cell, chronic lymphotic leukemia .c 3850 to 4290 441 to 1       441/441
(100 %)
2 diff
(99.6 %id)
BU153628 eye, retinoblastoma .c 3851 to 4290 1 to 439   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 439/439
(100 %)
2 diff
(99.6 %id)
FN110876 breast carcinoma .c 3858 to 3964 1 to 106       106/106
(100 %)
2 diff
(98.2 %id)
AA101812   .c 3877 to 4268 396 to 1       396/396
(100 %)
9 diff
(97.8 %id)
D60191 brain .c 3882 to 4290 407 to 1       407/407
(100 %)
2 diff
(99.6 %id)
CN295259 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .c 3887 to 4290 1 to 404   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 404/404
(100 %)
5 diff
(98.8 %id)
AI125668   .c 3887 to 4293 407 to 1       407/407
(100 %)
1 diff
(99.8 %id)
D60061   .c 3896 to 4290 389 to 1       389/389
(100 %)
0 diff
(100 %id)
BF223808 pooled germ cell tumors .c 3907 to 4290 384 to 1       384/384
(100 %)
1 diff
(99.8 %id)
BG611294 adenocarcinoma, Prostate .c 3907 to 4636 1 to 723       723/821
(88 %)
42 diff
(94.9 %id)
BG570846 placenta .c 4000 to 4345 1 to 348       348/928
(37 %)
8 diff
(99.2 %id)
D60041   .c 4044 to 4290 247 to 1       247/247
(100 %)
3 diff
(98.8 %id)
R32300 placenta .c 4059 to 4289 235 to 1       235/286
(82 %)
8 diff
(97.3 %id)
GD156058   .c 4061 to 4290 7 to 236   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 230/236
(97 %)
1 diff
(99.6 %id)
BC016000 Skin, melanotic melanoma, high MDR. .c 4065 to 5212 1 to 1150   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1150/1152
(99 %)
4 diff
(99.7 %id)
N56232   .c 4069 to 4320 1 to 253   tiling clone,   253/256
(98 %)
6 diff
(97.7 %id)
CB106534 Liver .c 4092 to 4599 1 to 509       509/509
(100 %)
1 diff
(99.9 %id)
AA730519 Ewing's sarcoma .c 4096 to 4300 205 to 1       205/205
(100 %)
3 diff
(98.6 %id)
AI474217 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 4105 to 4289 185 to 1       185/185
(100 %)
0 diff
(100 %id)
FN074560 breast carcinoma .c 4134 to 4232 96 to 1     Submitted on the opposite strand 96/97
(98 %)
3 diff
(97.0 %id)
BG253666 adenocarcinoma, cell line, Prostate .c 4163 to 4771 1 to 613       613/881
(69 %)
28 diff
(96.9 %id)
BF446783 carcinoid, lung .c 4168 to 4702 1 to 537     Submitted on the opposite strand 537/537
(100 %)
2 diff
(99.7 %id)
BE502955 carcinoid, lung .c 4175 to 4650 1 to 478     Submitted on the opposite strand 478/478
(100 %)
2 diff
(99.6 %id)
AA923411 pooled .c 4207 to 4290 82 to 1       82/82
(100 %)
2 diff
(97.6 %id)
BU151416 dorsal root ganglia .c 4243 to 5095 1 to 857       857/951
(90 %)
17 diff
(98.3 %id)
DT219217 brain .c 4276 to 4885 1 to 609       609/609
(100 %)
10 diff
(98.4 %id)
BM702702 eye, Retina Foveal and Macular .c 4296 to 4655 1 to 360   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 360/360
(100 %)
3 diff
(99.2 %id)
ES311982 frontal balding hair, skin .c 4298 to 4429 1 to 132       132/132
(100 %)
0 diff
(100 %id)
CK904298 Islets of Langerhans, Pancreas .c 4311 to 4823 1 to 513       513/513
(100 %)
0 diff
(100 %id)
BM021463 Islets of Langerhans, Pancreas .c 4327 to 4831 1 to 505       505/505
(100 %)
0 diff
(100 %id)
BE464532 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .c 4342 to 4787 466 to 21   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 446/446
(100 %)
0 diff
(100 %id)
BX106633 placenta .c 4358 to 5138 1 to 781       781/781
(100 %)
2 diff
(99.8 %id)
H87622 placenta .c 4358 to 4610 14 to 266       253/267
(94 %)
1 diff
(99.7 %id)
AI129359 uterus .c 4363 to 4856 494 to 1       494/494
(100 %)
0 diff
(100 %id)
FN130252 breast carcinoma .c 4375 to 4472 99 to 2     Submitted on the opposite strand 98/100
(98 %)
0 diff
(100 %id)
FN167537 breast carcinoma .c 4375 to 4468 92 to 3     Submitted on the opposite strand 90/92
(97 %)
0 diff
(100 %id)
FN140646 breast carcinoma .c 4387 to 4492 1 to 103       103/103
(100 %)
2 diff
(98.1 %id)
AV682704 hepatocellular carcinoma .c 4407 to 5133 1 to 723   AAA   723/790
(91 %)
18 diff
(97.8 %id)
AW188495 colon, moderately differentiated adenocarcinoma .c 4438 to 4857 425 to 5       421/425
(99 %)
0 diff
(100 %id)
BF130625 hypernephroma, Kidney .c 4481 to 5148 1 to 663       663/676
(98 %)
28 diff
(95.9 %id)
AA724574 pooled .c 4485 to 4857 379 to 7       373/379
(98 %)
0 diff
(100 %id)
AA642103   .c 4572 to 4925 1 to 354       354/354
(100 %)
0 diff
(100 %id)
TI_149283759   .c 4641 to 5227 51 to 637     Submitted on the opposite strand 587/762
(77 %)
6 diff
(99.3 %id)
BM984175 lung, Primary Lung Epithelial Cells .c 4650 to 5214 1 to 565   AAA Submitted on the opposite strand 565/565
(100 %)
4 diff
(99.3 %id)
AI634880 Kidney .c 4654 to 5145 492 to 1       492/492
(100 %)
0 diff
(100 %id)
BU156415 eye, retinoblastoma .c 4664 to 5215 554 to 1     Submitted on the opposite strand 554/595
(93 %)
3 diff
(99.5 %id)
TI_158434266   .c 4665 to 5227 780 to 219   AAA   562/1250
(44 %)
0 diff
(100 %id)
AA121673 lung, lung carcinoma .c 4682 to 5213 533 to 2   AAA Submitted on the opposite strand 532/589
(90 %)
0 diff
(100 %id)
BM021190 Islets of Langerhans, Pancreas .c 4694 to 5227 536 to 3       534/536
(99 %)
0 diff
(100 %id)
BQ013454 placenta .c 4737 to 5220 502 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 484/484
(100 %)
2 diff
(99.6 %id)
AI224110 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 4751 to 5215 465 to 1       465/465
(100 %)
0 diff
(100 %id)
AI417922 Prostate .c 4751 to 5216 470 to 5       466/470
(99 %)
0 diff
(100 %id)
AA720580 germinal center B-cells, tonsil .c 4753 to 5216 469 to 7       463/469
(98 %)
0 diff
(100 %id)
BG272471 head/neck, nasopharyngeal carcinoma .c 4759 to 5214 517 to 62   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 456/504
(90 %)
1 diff
(99.9 %id)
AI571001 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 4761 to 5216 456 to 1       456/456
(100 %)
2 diff
(99.6 %id)
N47469 multiple sclerosis lesions .c 4770 to 5214 446 to 1       446/447
(99 %)
1 diff
(99.8 %id)
AI285001 adenocarcinoma, colon .c 4789 to 5216 430 to 3   tiling clone,   428/430
(99 %)
0 diff
(100 %id)
AA948396 adenocarcinoma, colon .c 4793 to 5216 426 to 3       424/426
(99 %)
0 diff
(100 %id)
AI087832 pooled .c 4797 to 5216 421 to 2       420/421
(99 %)
0 diff
(100 %id)
AI923065 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 4810 to 5214 431 to 27   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 405/405
(100 %)
1 diff
(99.8 %id)
BQ012001 placenta .c 4953 to 5220 286 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 268/268
(100 %)
1 diff
(99.7 %id)
H87623 placenta .c 4993 to 5217 225 to 1   tiling clone,   225/227
(99 %)
1 diff
(99.6 %id)
EH351743   .c 5146 to 5211 1 to 68   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 68/72
(94 %)
7 diff
(90.3 %id)
FN065019 breast carcinoma .c 5157 to 5212 58 to 3     Submitted on the opposite strand 56/58
(96 %)
0 diff
(100 %id)
AK094701 amygdala .d 1 to 2933 2 to 2932 M499T N613D N760H tiling clone, available from FLJ,   2932/2932
(100 %)
5 diff
(99.9 %id)
DA165143 amygdala .d 1 to 567 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
AV647558 corresponding non cancerous liver tissue .d 35 to 612 1 to 578     Submitted on the opposite strand 578/578
(100 %)
3 diff
(99.5 %id)
DB302354 amygdala .d 2706 to 2931 226 to 3   tiling clone,   224/226
(99 %)
0 diff
(100 %id)
CN357227 embryonic stem cells, cell lines H1, H7, andH9 .e 1 to 463 6 to 469 G29R G30R G31R G32H G33P ... tiling clone,   469/469
(100 %)
11 diff
(97.7 %id)
AV704915 adrenal gland Gene ZNF281, variant not shown         Suspected internal deletion, this clone was ignored    
AV701683 adrenal gland Gene ZNF281, variant not shown         Suspected internal deletion, this clone was ignored    
AK297233 brain Gene ZNF281, variant not shown         Suspected internal deletion, this clone was ignored    
DA021194   Gene ZNF281, variant not shown       capped Suspected internal deletion, this clone was ignored    
DA446894 tongue, tumor tissue Gene ZNF281, variant not shown       capped This clone was ignored    
DA490123 brain Gene ZNF281, variant not shown       capped Suspected internal deletion, suspected internal deletion, this clone was ignored    
DC350303 brain Gene ZNF281, variant not shown         Suspected internal deletion, this clone was ignored    
AA252382 germinal center B cell Gene ZNF281, variant not shown         This clone was ignored    
DB095391 testis Gene ZNF281, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a-u, .b, .c, .d, .e Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI